Zynex, Inc., a company that designs, manufactures, and markets medical devices for the electrotherapy and stroke rehabilitation markets, announced that it has been granted FDA 510(k) clearance for its NexWave Medical device.
The NexWave device is the next wave in electrotherapy treatment and will be manufactured, marketed and sold through its subsidiary Zynex Medical. This device is capable of delivering three modalities of stimulation; interferential and neuromuscular electrical stimulation, and traditional TENS. The combined modalities of the NexWave offer a wide variety of muscle and pain rehabilitation therapies using just one device.
Zynex’s CEO, Thomas Sandgaard, commented, “We are very excited about the market introduction of this new product. The combined modalities of our NexWave provide doctors and clinicians a more comprehensive pain therapy solution for their patients. This device was designed with the patient in mind, as it is compact and easy to use, and falls under existing medical billing codes. We believe this new product is unique in the electrotherapy industry and provides our sales force with a competitive edge to fuel revenue generation in our already rapidly growing Zynex Medical subsidiary.”
For more information on the Company and its recent developments, visit their website at www.zynexmed.com
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment